Drug intelligence / Profile preview

hyaluronic acid + silver sulfadiazine

Development stage
Unknown
Lead developer
Fidia Farmaceutici
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

A topical pharmaceutical combination of hyaluronic acid and silver sulfadiazine used primarily for the treatment and prevention of wound infections in burns and chronic wounds. Hyaluronic acid is a naturally occurring glycosaminoglycan that promotes tissue repair by supporting cell migration, proliferation, granulation tissue formation, and modulating inflammation. Silver sulfadiazine is a sulfonamide antibiotic with broad-spectrum antimicrobial activity against gram-positive bacteria, gram-negative bacteria, and some fungi; it acts by releasing silver ions that disrupt microbial cell walls and DNA. The combination leverages the regenerative properties of hyaluronic acid with the antimicrobial effects of silver sulfadiazine to accelerate healing while reducing infection risk. This fixed-dose product is indicated for second-degree burns, chronic ulcers (including diabetic ulcers), post-traumatic wounds, superficial abrasions, parastomal ulcerations, and other complicated skin lesions at risk of infection[1][2][4][8].

Brand names
Connettivina PlusHYALO4 Control CreamHYALO-4 Control CreamHYALO 4 Control Cream
Other names
HA-SSDHA+SSDhyaluronic acid and silver sulfadiazine combination cream
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on hyaluronic acid + silver sulfadiazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + silver sulfadiazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call